MET Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
Jochen K Lennerz, Eunice L Kwak, Allison Ackerman, Michael Michael, Stephen B Fox, Kristin Bergethon, Gregory Y Lauwers, James G Christensen, Keith D Wilner, Daniel A Haber, Ravi Salgia, Yung-Jue Bang, Jeffrey W Clark, Benjamin J Solomon, A John Iafrate
Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2011
Awarded by National Cancer Institute
Supported by Pfizer and by National Cancer Institute Grant No. 5R01CA125541-05 (R.S).